17(2): 212-23. PF-06936308 C3621001 Final Protocol Amendment 2, 22 Dec 2020 PFIZER CONFIDENTIAL Page 13338. Bolonaki I, Kotsakis A, Papadimitraki E, et al. Vaccination of Patients With Advanced Non–Small -Cell L ung Cancer With an O ptimized Cry ptic Human Telomerase Reverse Transcriptase Peptide. Journal of Clinical Oncology . 2007;25(19):2727 -34. 39. Gucalp A, Traina TA. Triple -negative breast cancer: Adjuvant therapeutic options. Chemother Res Pract. 2011; 696208. 40. Hafft y BG, Yang Q, Reis s M, et al. L ocoregional relapse and distant metastasis in conservativel y managed triple negative earl y -stage breast cancer. J Clin Oncol. 2006; 24:5652-5657. 41.